Login
$ABT
$106.76 -$0.69 (0.64%) After hours

$ABT 8-K/A SEC Filings

Filed On Filing
01 Sep 2023 8-K/A: Submission of Matters to a Vote of Security Holders

On May 2, 2023, Abbott filed a Current Report on Form 8-K summarizing the matters voted on at its Annual Meeting of Shareholders held on April 28, 2023 (the “Original Report”). This amendment corrects the number of shares cast against Mi...

09 Jun 2023 8-K/A: Submission of Matters to a Vote of Security Holders

On May 2, 2023, Abbott filed a Current Report on Form 8-K summarizing the matters voted on at its Annual Meeting of Shareholders held on April 28, 2023 (the “May 2, 2023 Form 8-K”).

20 Jun 2017 8-K/A: Submission of Matters to a Vote of Security Holders

On May 3, 2017 Abbott filed a Form 8-K summarizing the matters voted on at its Annual Meeting of Shareholders held on April 28, 2017 (the “May 3, 2017 Form 8-K”).

21 Feb 2017 8-K/A: Completion of Acquisition or Disposition of Assets

QuickLinks -- Click here to rapidly navigate through this document

05 Mar 2015 8-K/A: Completion of Acquisition or Disposition of Assets

On February 27, 2015, Abbott Laboratories (“Abbott”) completed the sale of its developed markets branded generics pharmaceuticals business (“Business”) to Mylan in exchange for 110 million ordinary shares of Mylan N.V.

24 Feb 2014 8-K/A: Changes in Registrant's Certifying Accountant

We have read Item 4 of Abbott Laboratories’ Form 8-K/A dated February 21, 2014, and have the following comments:

01 Jun 2012 8-K/A: Departure/Election of Directors or Officers; Compensation

Effective June 1, 2012, Brian J. Blaser is Abbott’s Executive Vice President, Diagnostic Products, replacing Edward L. Michael, whose previously-announced retirement will be effective June 30, 2012.

16 Jun 2011 8-K/A: Submission of Matters to a Vote of Security Holders

On May 5, 2011 Abbott filed a Form 8-K summarizing the matters voted on at its Annual Meeting of Shareholders held on April 29, 2011 (the “May 5, 2011 Form 8-K”).

31 Jan 2005 8-K/A: Departure/Election of Directors or Officers; Compensation

On January 25, 2005, William M. Daley was appointed to the Compensation Committee and the Public Policy Committee of the Abbott Board of Directors. As previously reported on Abbott’s Current Report on Form 8-K filed October 15, 2004, Mr....

02 May 2002 8-K/A: Changes in Registrant's Certifying Accountant

Arthur Andersen LLP 33 West Monroe Street Chicago IL 60603-5385 Tel 312 580 0030 www.andersen.com

01 Apr 2002 8-K/A: Changes in Registrant's Certifying Accountant

QuickLinks -- Click here to rapidly navigate through this document

14 May 2001 8-K/A: Financial Statements and Exhibits

BASF PHARMACEUTICAL BUSINESS CONSOLIDATED STATEMENTS OF INCOME (EUROS IN MILLIONS)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support